Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Potassium two pore domain channel subfamily K (K2P channel family) comprises a group of potassium channels that possess two pore (P) domains per subunit and form "leak" or background potassium channels. These channels are constitutively active across the physiological voltage range, primarily responsible for setting and stabilizing the resting membrane potential and modulating the input resistance of cells—especially in neurons and excitable tissues. The family consists of multiple members (e.g., TREK-1 [KCNK2], TREK-2 [KCNK10], TASK-1, TWIK-1, TRESK, etc.) with distinct but overlapping expression patterns and regulatory mechanisms. K2P channels are major modulatory targets for endogenous neuromodulators, clinical anesthetics, and various chemical and mechanical stimuli. Dysregulation and pharmacological targeting of these channels are implicated in a wide array of neurological, cardiovascular, and pain disorders. Note: For structured data or drug interaction work, always specify the exact member (e.g., KCNK2, KCNK10) rather than the family as a whole to assure clinical and research precision.
Channel openers/activators (enhancing K+ efflux, stabilizing membrane potential, reducing excitability) - Channel blockers/inhibitors (reducing K+ efflux, enhancing excitability) - Modulation by endogenous lipids or changes in pH (allosteric modulation)
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium two pore domain channel subfamily K member (K2P channel).